FDA
approval
· 2011-04-15
FDA Approved: LOTEMAX — Original Application (Bausch & Lomb Incorporated)
Summary
FDA approved Lotemax (loteprednol etabonate) under Original Application (NDA200738) for ophthalmic use to treat inflammatory conditions of the eye and for relie…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LOTEMAX (LOTEPREDNOL ETABONATE)